NCT05768399Recruiting
The Role of Biomarkers in the Occurrence and Development of Asthma
Source: ClinicalTrials.gov · Last updated 7 Jul 2023 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
To study the expression level of biomarkers such as GITRL in peripheral blood of children with asthma and analyze their correlation with the severity of asthma. To study the predictive value of biomarkers level for the occurrence and development of asthma. And to provide supplementary detection means and predictive indicators for the diagnosis of asthma and the severity of asthma.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 2 (estimated)
- First submitted
- 7 Feb 2023
- Start date
- 4 Jul 2023
- Primary completion date
- 31 Dec 2028
- Lead sponsor
- Children's Hospital of Chongqing Medical University
- Diseases
- Asthma
- NCT number
- NCT05768399
What you commit to
- Study type: Observational
- Planned participants: 2
- From 4 Jul 2023 to the primary completion date, 31 Dec 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Suffering from other respiratory diseases (such as bronchiectasis, allergic rhinitis, respiratory failure, tuberculosis, obstructive airway disease) or other inflammatory diseases.
- History of immunosuppressant or glucocorticoid use in the first 4 weeks
- Suffering from other endocrine system and immune system diseases
Other
- Abnormal development of congenital airway and lung tissue
- Incomplete clinical data or examinations.
Who the study is looking for
- In line with the diagnostic criteria in the Guidelines for the Diagnosis and Prevention of Bronchial Asthma in Children (2016 Edition)
- Age: 4-12 years old for new diagnosis or recurrent episodes
- Typical clinical manifestations and complete clinical data
- Family members or guardians of children with informed research and signed consent
- All healthy control subjects had no history of lung disease, allergic rhinitis or any other atopic disease
Age in the registry: 4 years to 12 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Shaoqing Zhang Coordinator of this site? Confirm its status | Chongqing | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.